Graeme J. Moyle

Corporate Officer/Principal bei Chelsea & Westminster Hospital

60 Jahre

Health Technology

Consumer Services

Aktive Positionen von Graeme J. Moyle

Unternehmen	Position	Beginn	Ende
Chelsea & Westminster Hospital	Corporate Officer/Principal	01.01.1994	-

Unternehmen	Position	Beginn	Ende
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Direktor/Vorstandsmitglied	23.06.2014	-
	Independent Dir/Board Member	23.06.2014	-

University of Adelaide

Doctorate Degree

International

Operativ

Director/Board Member	1
Independent Dir/Board Member	1
Doctorate Degree	1

Sektoral

Health Technology	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	2
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Health Technology
Chelsea & Westminster Hospital

Private Unternehmen

Health Technology

Chelsea & Westminster Hospital